 This study investigated the effectiveness of a parenteral form of chondroitin sulfate, CS, in treating knee osteoarthritis, OA. It found that CS had beneficial effects on the morphology of the knee joints, reducing inflammation and improving the structural integrity of the joints. This suggests that CS may be useful for treating knee OA. This article was authored by TB Minasov, AM Lila, AG Nazarenko, and others.